Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of the iStent Versus Two Ocular Hypotensive Agents in Patients With Primary Open-angle Glaucoma (POAG)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of primary open-angle glaucoma~* Male or female at least 18 years of age and able to provide written informed consent~* Mean IOP (at baseline visit after washout of any medications) must be 22 mm Hg and no greater than 38 mm Hg~* Likely to be available and willing to attend follow-up visits~Exclusion Criteria:~* Angle closure glaucoma~* Secondary glaucomas~* Prior glaucoma procedures~* Elevated episcleral venous pressure from history of active thyroid orbitopathy, carotid-cavernous fistula, orbital tumors, or orbital congestive disease

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Stent (Type: ACTIVE_COMPARATOR): One hundred patients will be randomized to implantation of two G2 stents in at least one eye.
- Medication (Type: ACTIVE_COMPARATOR): One hundred patients will be randomized to receive a fixed combination ocular hypotensive medication.

Based on this trial design, predict the completion outcome and termination type (if applicable).